• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.

作者信息

Glassock Richard J

机构信息

Department of Medicine, Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California

出版信息

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1341-3. doi: 10.2215/CJN.05880614. Epub 2014 Jul 17.

DOI:10.2215/CJN.05880614
PMID:25035274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4123392/
Abstract
摘要

相似文献

1
Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.抗磷脂酶A2受体自身抗体指导下的膜性肾病诊断与治疗：一种新的个性化医疗方法。
Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1341-3. doi: 10.2215/CJN.05880614. Epub 2014 Jul 17.
2
Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.抗磷脂酶A₂受体（PLA₂R）抗体与特发性膜性肾病免疫抑制治疗后结局的关联
Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1386-92. doi: 10.2215/CJN.10471013. Epub 2014 Jul 17.
3
Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.磷脂酶A2受体（PLA2R）抗体相关膜性肾病的免疫缓解：环磷酰胺与利妥昔单抗对比
Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019.
4
Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy.抗磷脂酶 A2 受体抗体阳性膜性肾病免疫抑制反应预测因素分析。
BMC Nephrol. 2018 Dec 12;19(1):354. doi: 10.1186/s12882-018-1160-6.
5
Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.在膜性肾病临床表现出现之前，血清抗磷脂酶A2受体（PLA2R）抗体可能已经存在。
Kidney Int. 2016 Jun;89(6):1399. doi: 10.1016/j.kint.2015.11.032.
6
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.原发性膜性肾病患者的M型磷脂酶A2受体自身抗体与肾功能
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29.
7
Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies.评价利妥昔单抗治疗膜性肾病的疗效：11 项研究的系统评价和荟萃分析。
Nephrol Ther. 2022 Apr;18(2):104-112. doi: 10.1016/j.nephro.2021.10.002. Epub 2022 Jan 21.
8
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.抗 M 型磷脂酶 A2 受体 (PLA2R) 自身抗体在鉴别特发性膜性肾病 (IMN) 与继发性及其他肾小球疾病中的诊断特异性。
J Nephrol. 2018 Apr;31(2):271-278. doi: 10.1007/s40620-017-0451-5. Epub 2017 Oct 28.
9
Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.磷脂酶 A2 受体抗体、24 小时蛋白尿和血清白蛋白作为环磷酰胺治疗特发性膜性肾病疗效的指标。
J Clin Lab Anal. 2020 Sep;34(9):e23368. doi: 10.1002/jcla.23368. Epub 2020 May 24.
10
Treatment of primary membranous nephropathy: where are we now?原发性膜性肾病的治疗：我们现在在哪里？
J Nephrol. 2018 Aug;31(4):489-502. doi: 10.1007/s40620-017-0427-5. Epub 2017 Sep 5.

引用本文的文献

1
Hypothetical Pathogenetic Model of Membranous Nephropathy.膜性肾病的假设发病机制模型。
Int J Mol Sci. 2025 Feb 28;26(5):2206. doi: 10.3390/ijms26052206.
2
Mannose-Binding Lectin Deposition in Membranous Nephropathy and Differentiation of Primary from Secondary Forms.甘露糖结合凝集素沉积在膜性肾病及原发性与继发性形式的鉴别。
Int J Mol Sci. 2024 Jul 12;25(14):7659. doi: 10.3390/ijms25147659.
3
Diagnostic Usefulness of Antibodies Against M-type Phospholipase A2 Receptor (aPLA2R) in Primary Membranous Nephropathy in the Mexican Population.抗M型磷脂酶A2受体（aPLA2R）抗体在墨西哥人群原发性膜性肾病中的诊断价值
Cureus. 2023 Aug 16;15(8):e43588. doi: 10.7759/cureus.43588. eCollection 2023 Aug.
4
The Role of Anti-PLAR and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice.抗 PLAR 和抗 THSD7A 抗体在原发性膜性肾病发病机制和诊断中的作用：临床实践的最新知识综述。
Int J Environ Res Public Health. 2022 Apr 27;19(9):5301. doi: 10.3390/ijerph19095301.
5
Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer.不同免疫抑制疗法对膜性肾病且抗磷脂酶A2受体（PLA2R）抗体滴度高的患者的疗效和安全性
Front Pharmacol. 2022 Jan 17;12:786334. doi: 10.3389/fphar.2021.786334. eCollection 2021.
6
Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy.自身抗体在膜性肾病的诊断、监测和治疗中的作用。
Front Immunol. 2021 Mar 22;12:593288. doi: 10.3389/fimmu.2021.593288. eCollection 2021.
7
A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor.伴有和不伴有抗磷脂酶A2受体血清抗体的特发性膜性肾病患者临床特征的比较
Medicine (Baltimore). 2019 Nov;98(45):e17658. doi: 10.1097/MD.0000000000017658.
8
A Proposal for a Serology-Based Approach to Membranous Nephropathy.一种基于血清学方法诊断膜性肾病的建议。
J Am Soc Nephrol. 2017 Feb;28(2):421-430. doi: 10.1681/ASN.2016070776. Epub 2016 Oct 24.
9
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy.抗磷脂酶A2受体自身抗体：原发性膜性肾病治疗的一大进展
Biomed Res Int. 2015;2015:249740. doi: 10.1155/2015/249740. Epub 2015 Oct 20.
10
Changing the concepts of immune-mediated glomerular diseases through proteomics.通过蛋白质组学改变免疫介导性肾小球疾病的观念。
Proteomics Clin Appl. 2015 Dec;9(11-12):967-71. doi: 10.1002/prca.201400159. Epub 2015 Jun 17.

本文引用的文献

1
Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.抗磷脂酶A₂受体（PLA₂R）抗体与特发性膜性肾病免疫抑制治疗后结局的关联
Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1386-92. doi: 10.2215/CJN.10471013. Epub 2014 Jul 17.
2
Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues.膜性肾病中的磷脂酶A2受体抗体：未解决的问题
J Am Soc Nephrol. 2014 Jun;25(6):1137-9. doi: 10.1681/ASN.2014010091. Epub 2014 Mar 7.
3
Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.磷脂酶 A2 受体自身抗体与原发性膜性肾病患者的临床结局。
J Am Soc Nephrol. 2014 Jun;25(6):1357-66. doi: 10.1681/ASN.2013040430. Epub 2014 Mar 7.
4
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.原发性膜性肾病中人 M 型磷脂酶 A2 受体自身抗体的酶联免疫吸附测定法的建立。
Clin Chim Acta. 2013 Jun 5;421:213-8. doi: 10.1016/j.cca.2013.03.015. Epub 2013 Mar 27.
5
American Society of Nephrology Quiz and Questionnaire 2012: glomerulonephritis.美国肾脏病学会测验与问卷 2012：肾小球肾炎。
Clin J Am Soc Nephrol. 2013 Aug;8(8):1460-5. doi: 10.2215/CJN.00440113. Epub 2013 Mar 28.
6
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.ELISA 检测的抗 PLA2R 抗体可预测特发性膜性肾病患者人群的长期预后。
Kidney Int. 2013 May;83(5):940-8. doi: 10.1038/ki.2012.486. Epub 2013 Jan 30.
7
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.肾活检是回顾性诊断 PLA2R 相关膜性肾病的敏感工具。
Nephrol Dial Transplant. 2013 Jul;28(7):1839-44. doi: 10.1093/ndt/gfs439. Epub 2012 Dec 6.
8
Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy.抗磷脂酶 A2 受体抗体滴度及其亚类在特发性膜性肾病中的变化。
J Am Soc Nephrol. 2012 Oct;23(10):1735-43. doi: 10.1681/ASN.2012030242. Epub 2012 Sep 6.
9
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.膜性肾病中不同循环抗足细胞抗体的共存。
Clin J Am Soc Nephrol. 2012 Sep;7(9):1394-400. doi: 10.2215/CJN.02170312. Epub 2012 Jul 5.
10
Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis.抗M型磷脂酶A2受体（PLA2R）抗体与膜性狼疮性肾炎
Am J Kidney Dis. 2012 Apr;59(4):585-6. doi: 10.1053/j.ajkd.2011.10.044. Epub 2011 Dec 16.